CLINICAL AMBASSADOR - DIVERSITY ENGAGEMENT
  • home
    • why us >
      • samples
    • harry's report
    • scope
    • overnight materials
  • About
    • capabilities
    • who we are
  • solutions
    • inclusion
  • Contact
  • coronavirus pandemic
Picture
These are difficult days fraught with unprecedented challenges. And we aim to do our part and contribute to real solutions. Toward that end— and beyond mere hope— we are here to help spread real education about prevention, detection and control of this pandemic, and establish agile, timely and appropriate responses that will be necessary for future global health crises. 

This is also an unprecedented time for the biopharmaceutical and research industry to gain traction in educating the public about clinical trials and the critical need for human participants in research. We can facilitate and accelerate your awareness projects on behalf of crisis-specific studies, crafting communication and helping industry pivot to make room for unexpected work plans and solutions.

As contributors to your scientific advances, Clinical Ambassador Health feels a similar sense of scientific urgency and social obligation. We are confident in our talent for helping in meaningful ways. 
We pledge to remain nimble, forward thinking and intent on evolving the ways we connect— safely— to ensure that our collective processes and outcomes contribute to ongoing development and global delivery of medicines to the people who need them most. We stand ready to relieve some of your burden and to assist you in rising to this occasion to support our global community.

Preparing for Our Continuity and Yours

Clients and Colleagues,
​
Our hearts extend to everyone battling the coronavirus around the world. At Clinical Ambassador Health, our priorities remain steadfast in promoting the most accurate and relevant information and to advocate for the safe participation of more people in clinical trials. At this time, possibly more that any other in modern history, it's essential that the process for discovering evidence-based medicine remain unencumbered. Toward that end, we know that our clients are focused on ensuring their employees’ health and safety while forging ahead toward new compounds with breakneck efficiency, and partnering with our customers, sponsors and investigators to deliver life-saving medicines to patients worldwide.


With that,Clinical Ambassador Health is making every effort to ensure this emergent situation will have minimal impact on the timeliness or quality of the work we do for you. Of course, we will continue to monitor the developing situation to ensure message alignment with FDA, CDC, WHO and all relevant local and international health authority guidances to assist our clients' best practice planning and preparedness activities. 

— Allison Kalloo, MPH, Founder & President

Responding to COVID-19

Individual actions create collective results.
—Dr. Patrice Harris, President, American Medical Association 2020
Pre-existing health disparities that cause disproportionate  minorities Diversity in clinical trials could not be more urgent than in this time of the coronavirus pandemic. Clinical Ambassador rises to answer this calling to address awareness and access, and helps solve the problem

EDUCATION— What You Need to Know

  • NIH on the Phase 3 MODERNA Vaccine Trial: https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins
  • NIH launches clinical trial NETWORK: https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tools
  • CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
  • WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • Johns Hopkins: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus
  • Harvard: ​https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center
  • POLITICO: https://www.politico.com/news/2020/03/29/fda-emergency-authorization-anti-malaria-drug-155095
  • ​GENENGNEWS: https://www.genengnews.com/news/promising-broad-spectrum-antiviral-emerges-for-covid-19-from-veteran-sars-lab/​
  • NPR: https://www.npr.org/sections/coronavirus-live-updates/2020/03/31/824572119/clinical-trials-set-to-determine-if-anti-malaria-drug-effective-against-covid-19​​​


CLINICAL TRIALS— Links to the Latest on Coronavirus

  • National Institutes of Health (NIH): https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins
  • ​CLINICALTRIALS.GOV Actively Recruiting Listings: 
    • https://clinicaltrials.gov/ct2/results?cond=Coronavirus&Search=Apply&recrs=a&age_v=&gndr=&type=&rslt= 
    • https://clinicaltrials.gov/ct2/show/NCT04427501
  • World Health Organization (WHO) Global Study Database: https://clinicaltrials.gov/ct2/who_table
  • MAYO Clinic Trials: https://www.mayo.edu/research/clinical-trials/diseases-conditions/coronavirus-disease-2019-(covid-19)

Questions? Reach out here!

HOME

ABOUT

SERVICES

CONTACT

© MMXX Clinical Ambassador Health Incorporated. All rights reserved.
  • home
    • why us >
      • samples
    • harry's report
    • scope
    • overnight materials
  • About
    • capabilities
    • who we are
  • solutions
    • inclusion
  • Contact
  • coronavirus pandemic